A study to determine the effect of ondansetron in prevention of hypotension in caesarean delivery under spinal anaesthesia
Phase 3
- Conditions
- Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2021/10/037517
- Lead Sponsor
- Dr Monisha Ravichandran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Parturients aged 18 to 45 years
2)American Society Of Anesthesiologits physical status less than III
3)Singleton term pregnancy(more than 37 weeks gestation)
4)Scheduled for elective caesarean delivery under regional anaesthesia
Exclusion Criteria
1)Patient refusal
2)Hypersensitivity to Ondansetron
3)Contraindication for spinal anesthesia
4)Hypertensive disorders and diabetes with pregnancy
5)History of nausea,vomiting during the 24 hours before induction of anaesthesia
6)Multiple gestation
7)Patient receiving selective serotonin reuptake inhibitor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To estimate the magnitude of the effect of Ondansetron versus placebo in reducing the incidence of spinal anaesthesia induced hypotension during caesarean deliveryTimepoint: 1 Year
- Secondary Outcome Measures
Name Time Method The requirement of phenylephrine,ephedrine and atropine. <br/ ><br> <br/ ><br>Timepoint: 1 Year